The Klebsiella pneumoniae project KLEB-GAP is lead by PI Arnfinn Sundsfjord and Co-PI Iren Høyland Löhr. KLEB-GAP is a large, new project involving several Norwegian and international institutions who aim to provide new insights into the ecology, antmicrobial resistance and pathogenicity of Klebsiella pneumoniae. Klebsiella is a key driver in the global spread of antimicrobial resistance and a target for new approaches in diagnostics, surveillance and alternative therapeutics.
May 29, 2018
Funded by the Norwegian Research Council
Klebsiella pneumoniae has emerged as a high-risk human pathogen due to its virulence and increasing levels of antimicrobial resistance (AMR), and has by WHO been defined as one of the multidrug resistant (MDR) bacteria posing the greatest threat ...
The AMR group at Stavanger University Hospital and Holtlab have a new preprint on te convergence of virulence and MDR in a single plasmid in Klebsiella pneumoniae clone ST15. Click to read the abstract and access the full article.
Members of the AMR group at Stavanger University Hospital and Holtlab have a new preprint of their work on a new carbapenemase producing Klebsiella pneumoniae clone, ST307. Click to read the abstract and access the full article.